Search clinical trials for: Comparator: Micafungin sodium

Total 12295 results

Merck Sharp & Dohme LLC

Completed

A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)

Fungal Infection
Seoul National University Hospital

Unknown

Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Neutropenia | Fungal Disease

Korea, Republic of
Shandong Provincial Hospital

Recruiting

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease

China
Clinical Nutrition Research Center, Illinois Institute...

Completed

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance (GSE3)

Impaired Glucose Tolerance

United States
Astellas Pharma Singapore Pte. Ltd.

Completed

Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study

Invasive Fungal Infections

Hong Kong, Korea, Republic of, Singapore, Taiwan, Thailand
Shanghai General Hospital, Shanghai Jiao Tong University...

Not yet recruiting

To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation

Liver Transplantation
University Hospital, Limoges

Completed

Pharmacokinetics of Micafungin in Patients of Intensive Care Units (MI-K)

Invasive Candidiasis

France
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin in Patients Intensive Care Unit (MIMIC)

Invasive Fungal Infection

Netherlands
Astellas Pharma Inc

Completed

Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States
Radboud University Medical Center

Completed

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease (MATADOR)

Allogeneic Stem Cell Transplant | Acute Myeloid Leucaemia | Myelo Dysplastic Syndrome | Acute Graft Versus Host Disease Grade II-IV

Netherlands, Belgium
Astellas Pharma Inc

Completed

A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects (INTENSE)

Mycoses

Belgium, Germany, Spain, France, Italy, Turkey, Austria, Switzerland, Hungary, United Kingdom, Israel, Denmark, Greece, Finland, Romania
Tecno Sun SRL
Centro Studi Gised

Withdrawn

Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis

Inverse Psoriasis | Sebopsoriasis

Italy
Tecno Sun SRL
Centro Studi Gised

Terminated

Efficacy of Aerosal® in the Treatment of Sub-Obstructive Adenotonsillar Hypertrophy and Related Diseases

Sleep Apnea, Obstructive

Italy
University of Padova

Completed

Ultrasound Findings to Adjust the Duration of Anticoagulation (AESOPUS)

Deep Vein Thrombosis

Italy
Eunice Kennedy Shriver National Institute of Child...

Terminated

Micafungin Lock Therapy

Catheter-Related Fungal Infections

United States
Gary E. Stein, Pharm.D.
Astellas Pharma US, Inc.

Completed

Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins

Candidemia

United States
Astellas Pharma Inc

Completed

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis

Candidiasis, Oral

Argentina, South Africa, Brazil, Peru
Centre Hospitalier Universitaire de Nīmes

Completed

Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis

Septic Shock | Peritonitis

France, Australia
Astellas Pharma China, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia

Candidemia | Candidiasis

China
Astellas Pharma China, Inc.

Terminated

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Candidiasis | Aspergillosis

China
Medical University of Vienna

Completed

Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration (Mica-HDF)

Candida Sepsis

Austria
Astellas Pharma China, Inc.

Terminated

Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive Aspergillosis

Invasive Aspergillosis

China
Nantes University Hospital

Completed

Antifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD) (MycaCOORD)

Invasive Fungal Infection

France
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Completed

Alternate Day Micafungin: A PK Study in Pediatric Patients

Fungal Infection

United States
National Cancer Institute (NCI)

Completed

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia

Mycoses | Neutropenia | Fever

United States
Yung Shin Pharm. Ind. Co., Ltd.

Completed

Evaluate Bioequivalence of Micafungin (50mg/Vial)

Invasive Candidiasis

Taiwan
Astellas Pharma Global Development, Inc.
IRCCS, Ospedale Pediatrico Bambino Gesu

Completed

Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis

Candidiasis, Systemic | Candida Meningitis

Italy
Astellas Pharma China, Inc.

Completed

A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections

Invasive Fungal Infections

China
University of Texas Southwestern Medical Center
Astellas Pharma US, Inc.

Completed

Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers (Micafungin)

Obesity | Nutrition Disorders | Overweight

United States
Astellas Pharma Inc

Completed

Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

Candidemia | Invasive Candidiasis | Esophageal Candidiasis | Oropharyngeal Candidiasis

United States, South Africa
Children's Hospital Medical Center, Cincinnati
Astellas Pharma Inc

Terminated

A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis (Micafungin)

Cancer | Immunocompromised | Bone Marrow Transplant

United States
Radboud University Medical Center
Astellas Pharma Inc; St. Antonius Hospital

Completed

Micafungin Pharmacokinetics in Obese Patients (MICADO)

Morbid Obesity

Netherlands
Astellas Pharma Inc

Completed

An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates

Candida

United States
Astellas Pharma Inc

Completed

Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis

Candidiasis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
Asan Medical Center
Astellas Pharma Korea, Inc.

Unknown

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Neutropenia | Hematopoietic Stem Cell Transplantation | Invasive Fungal Disease

Korea, Republic of
Yonsei University

Completed

Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases

Febrile Neutropenia | Hematological Diseases

Korea, Republic of
Seoul National University Hospital
Astellas Pharma Inc

Completed

Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia

Acute Leukemia
Astellas Pharma S.A.S.

Completed

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology (OLYMPE)

Antifungal Prophylaxis | Haemopathy

France
National University Hospital, Singapore

Unknown

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Indications for Warfarin Therapy

Singapore, Malaysia
Astellas Pharma Inc

Completed

A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children and Adolescents Who Undergo Hematopoietic Stem Cell Transplant

Fungal Infections

United States
University of Delaware

Completed

Adverse Neurogenic Actions of Dietary Salt

Blood Pressure

United States
Astellas Pharma Inc

Terminated

Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

Invasive Fungal Infections

United States, Canada
University Hospital, Grenoble

Completed

Empirical Antifungal Treatment in ICUS (EMPIRICUS)

Invasive Candidiasis

France
Johns Hopkins University

Completed

Normal Saline Use With Suctioning

Tracheostomy

United States
Kevin Watt

Completed

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

Invasive Candidiasis

United States
Organon and Co

Completed

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Osteoporosis Postmenopausal
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)

Urinary Tract Infection
Astellas Pharma Inc

Completed

Study of FK463 for the Treatment of Invasive Aspergillosis

Aspergillosis

United Kingdom, Austria, France, Germany, Italy, Poland, Spain, Sweden
North Carolina State University

Completed

Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

Hyperglycemia

United States
Eisai Inc.

Completed

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

Alzheimer's Disease

United States

Search clinical trials for: Comparator: Micafungin sodium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations